• Hohyun Kim, Chang Ho Jeon, Jae Hun Kim, Hyun-Woo Sun, Dongyeon Ryu, Kang Ho Lee, Chan Ik Park, Jae Hoon Jang, Sung Jin Park, and Seok Ran Yeom.
• Department of Trauma and Surgical Critical Care, Pusan National University Hospital, 179 Gudeok-Ro, Seo-Gu, Busan, 602-739, Korea.
• Eur J Trauma Emerg Surg. 2021 Dec 1; 47 (6): 1661-1669.

IntroductionTransarterial embolisation (TAE) is an effective intervention for management of arterial haemorrhage associated with pelvic fracture. However, its effects on survival and clinical outcomes are unclear.MethodsTrauma patients with survival data between November 2015 and December 2019 were identified using a trauma database. Patients were divided between TAE and non-TAE groups, and a propensity score was developed using multivariate logistic regression. Survival at 28 days was compared between the groups after propensity score matching.ResultsAmong 881 patients included in this study, 308 (35.0%) were treated with TAE. After propensity score matching, 130 pairs were selected. Survival at 28 days was significantly higher among patients treated with TAE than among those treated without TAE [122 (93.9%) vs. 112 (86.2%); odds ratio = 2.45; 95% CI 1.02-5.86; p = 0.039].ConclusionsTAE use was associated with improved survival at 28 days in patients with pelvic fracture and should therefore be considered in the management of severely injured patients with pelvic fracture.© 2020. The Author(s).

13 keywords...

hide…